These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3530116)

  • 61. [Mediated effect of antitumor drugs].
    Chernov VA
    Vestn Akad Med Nauk SSSR; 1977; (10):70-4. PubMed ID: 919753
    [No Abstract]   [Full Text] [Related]  

  • 62. The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcoma.
    Langdon SP; Gescher A; Hickman JA; Stevens MF
    Eur J Cancer Clin Oncol; 1984 May; 20(5):699-705. PubMed ID: 6428895
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Carboplatin and neuroblastoma.
    Pritchard J; Hill BT; Kellie S; Whelan RD
    Lancet; 1987 Jan; 1(8526):214-5. PubMed ID: 2880035
    [No Abstract]   [Full Text] [Related]  

  • 64. Proton NMR observation of the antineoplastic agent Iproplatin in vivo by selective multiple quantum coherence transfer (Sel-MQC).
    He Q; Bhujwalla ZM; Maxwell RJ; Griffiths JR; Glickson JD
    Magn Reson Med; 1995 Mar; 33(3):414-6. PubMed ID: 7760709
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Studies on antitumor agents. I. Antitumor activity of 5(4)-amino-4(5)-imidazolecarboxamide analogs.
    Hoshi A; Kumagai K; Kuretani K
    Chem Pharm Bull (Tokyo); 1968 Oct; 16(10):2080-3. PubMed ID: 5710941
    [No Abstract]   [Full Text] [Related]  

  • 66. Evaluation of antitumor efficiency of experimental interstitial photodynamic therapy on the model of M1 sarcoma.
    Skugareva OA; Kaplan MA; Malygina AI; Mikhailovskaya AA
    Bull Exp Biol Med; 2009 Nov; 148(5):807-9. PubMed ID: 20396798
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preclinical antitumor activity of orally administered platinum (IV) complexes.
    Rose WC; Crosswell AR; Schurig JE; Casazza AM
    Cancer Chemother Pharmacol; 1993; 32(3):197-203. PubMed ID: 8500224
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes.
    Siddik ZH; al-Baker S; Burditt TL; Khokhar AR
    J Cancer Res Clin Oncol; 1993; 120(1-2):12-6. PubMed ID: 8270602
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    J Cancer Res Clin Oncol; 1994; 120(7):409-14. PubMed ID: 8188734
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatin.
    Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
    J Cancer Res Clin Oncol; 1994; 120(10):571-7. PubMed ID: 7929527
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Experimental antitumor activity of BMY-28090, a new antitumor antibiotic.
    Schurig JE; Bradner WT; Basler GA; Rose WC
    Invest New Drugs; 1989 Jul; 7(2-3):173-8. PubMed ID: 2793369
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30.
    Rose WC; Basler GA; Trail PA; Saulnier M; Crosswell AR; Casazza AM
    Invest New Drugs; 1990; 8 Suppl 1():S25-32. PubMed ID: 2380014
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent.
    Schurig JE; Rose WC; Kamei H; Nishiyama Y; Bradner WT; Stringfellow DA
    Invest New Drugs; 1990 Feb; 8(1):7-15. PubMed ID: 2345072
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E; van der Vijgh WJ; Nauta MM; Schlüper HM; Pinedo HM
    Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.
    Schroyens W; Dodion P; Rozencweig M
    J Cancer Res Clin Oncol; 1990; 116(4):392-6. PubMed ID: 2202731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preclinical antitumor and toxicologic profile of carboplatin.
    Rose WC; Schurig JE
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():1-19. PubMed ID: 3910215
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of platinol analogs using the M5076 murine sarcoma.
    Rose WC
    Anticancer Res; 1986; 6(4):557-62. PubMed ID: 3530116
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
    Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.